Viva Biotech Holdings filed its Annual on Apr 26, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 HKD | -3.17% | -6.15% | -41.90% |
03-28 | Viva Biotech Holdings Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-18 | Viva Biotech Holdings Appoints WANG Stephen Hui as Non-Executive Director | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.90% | 173M | |
+42.60% | 748B | |
+33.79% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+17.21% | 245B | |
+9.38% | 211B | |
-3.76% | 209B | |
+1.81% | 166B |
- Stock Market
- Equities
- 1873 Stock
- News Viva Biotech Holdings
- Viva Biotech Holdings Auditor Raises 'Going Concern' Doubt